Latest California Healthline Stories
Qué pueden hacer hospitales y consultorios para que los adultos mayores estén más seguros
Para los adultos mayores, especialmente para los que son frágiles, los centros médicos pueden ser difíciles de navegar y, a veces, hasta peligrosos.
Addiction Clinics Market Pricey, Unproven Treatments To Desperate Patients
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
Watch: Trump-Pence Policy Shift Makes Birth Control Harder To Get
The Trump administration’s policy shift on Title X family planning funds is likely to make birth control harder to get and more expensive for low-income women. It will also shift funds from organizations like Planned Parenthood to the Obria Group, which does not give women hormonal contraceptives or condoms in its clinics.
Pesadilla por acariciar a un gato: infecciones, rabia… y cuentas sorpresa
Por un simple gesto de afecto hacia un felino: tres visitas a la sala de emergencias, vacunas contra la rabia, agentes del orden animal y el dolor de no comprender las cuentas de salud.
A Brush With A Notorious Cat, My Rabies Education And The Big Bill That Followed
An encounter with a cat led to rabies shots and provided yet another illustration of how confusing, contrary and expensive the American health care system is.
Despite Failed Promises, Stem Cell Advocates Again Want Taxpayers To Pony Up Billions
California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.
This Indiana Clinic Has Patient-Care Stats Worth Bragging About
A small health center in Goshen, Ind., near the border with Michigan, puts “listening to patients’ stories” first. “The rest is housekeeping.”
Federal Suit Alleges ‘Staggering’ Urine Drug Testing Fraud At Tennessee Pain Clinics
Tennessee company’s Medicare billings for urine tests were examined by Kaiser Health News in 2017.
Stem Cell Company Persuades Employers To Steer Workers Toward Controversial Therapy
Regenexx, which runs a string of clinics, says stem cell injections can save employers a lot of money, but critics say there’s no proof.
KHN’s ‘What The Health?’: Fetal Tissue Research Is Latest Flashpoint In Abortion Debate
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the Trump administration’s efforts to curtail federally funded research using fetal tissue, the backlash from former Vice President Joe Biden’s support for the anti-abortion Hyde Amendment and how health policy intersects with both trade and immigration policy.